DuPont sells Aramids business (Kevlar, Nomex) to Arclin for $1.8B

DuPont de Nemours, Inc.

Transaction valued at ~$1.8B; DuPont to receive ~$1.2B cash, $300M note, and 17.5% equity stake in Arclin.
Aramids business includes Kevlar and Nomex brands; expected to close by May 1, 2026, subject to regulatory approvals.
Regulatory clearances needed from U.S., EU, Japan, China, South Korea, and UK.
DuPont will retain a non-controlling equity interest currently valued at $325M.
Pre-tax cash proceeds of ~$1.2B subject to customary adjustments.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.